Tagged:

Female HIV Prevention Trial Ends

A three-country study has been halted after daily doses of an antiretroviral, used as a pre-exposure prophylaxis, failed to prevent HIV infection in the women participating.
WHO/UNAIDS/Sven Torfin

An HIV-positive woman receives ARV treatment at a health centre in Botswana (file photo).

  • Africa:   Hopes Dashed in HIV Prevention Drug Trial

    Health-e, 19 April 2011

    A clinical trial aimed at investigating whether an antiretroviral pill a day could prevent women from getting HIV was abandoned yesterday. Read more »

  • Africa:   Trial of HIV Prevention Drug Disappoints

    PlusNews, 18 April 2011

    A three-country study has been halted after daily doses of the antiretroviral (ARV) Truvada, used as a pre-exposure prophylaxis (PrEP), failed to prevent HIV infection in the women… Read more »

  • Africa:   HIV Prevention Study to End

    FHI360, 19 April 2011

    Following a scheduled interim review of the FEM-PrEP study data, the Independent Data Monitoring Committee (IDMC) advised that the FEM-PrEP study will be highly unlikely to be able… Read more »

Follow AllAfrica

AllAfrica publishes around 400 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.